Overview

Mechanisms of Insulin Resistance in Critical Illness: Role of Systemic Inflammation and GLP-1

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the role of inflammation and the insulin regulating hormone GLP-1 during critical illness.
Phase:
N/A
Details
Lead Sponsor:
Rigshospitalet, Denmark
Collaborators:
Novo Nordisk A/S
University of Copenhagen
Treatments:
Glucagon
Glucagon-Like Peptide 1